Importance of background rates of disease in assessment of vaccine safety during mass immunisation with pandemic H1N1 influenza vaccines
- 1 January 2010
- journal article
- Published by Elsevier BV in The Lancet
- Vol. 374 (9707), 2115-2122
- https://doi.org/10.1016/s0140-6736(09)61877-8
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Incidence of acquired demyelination of the CNS in Canadian childrenNeurology, 2009
- The Incidence of Neuro-Ophthalmic Diseases in Singapore: A Prospective Study in Public HospitalsOphthalmic Epidemiology, 2009
- The prevalence of preterm birth and season of conceptionPaediatric and Perinatal Epidemiology, 2008
- Anaphylaxis following quadrivalent human papillomavirus vaccinationCMAJ : Canadian Medical Association Journal, 2008
- Contribution of incidence to increasing prevalence of multiple sclerosis in Alberta, CanadaMultiple Sclerosis Journal, 2008
- First seizure definitions and worldwide incidence and mortalityEpilepsia, 2008
- Childhood idiopathic thrombocytopenic purpura in the Nordic countries: Epidemiology and predictors of chronic diseaseActa Paediatrica, 2005
- Childhood idiopathic thrombocytopenic purpura in the Nordic countries: Epidemiology and predictors of chronic diseaseActa Paediatrica, 2005
- Methods: Retrospective hospital‐based searches for cases of acute flaccid paralysisAustralian and New Zealand Journal of Public Health, 2002
- Influence of past reproductive performance on risk of spontaneous abortion.BMJ, 1989